Revance Therapeutics
RVNC
#6857
Rank
NZ$0.75 B
Marketcap
$7.23
Share price
2.66%
Change (1 day)
-26.75%
Change (1 year)

Market capitalization of Revance Therapeutics (RVNC)

Market cap: NZ$0.75 Billion

As of November 2024 Revance Therapeutics has a market cap of NZ$0.75 Billion. This makes Revance Therapeutics the world's 6857th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Revance Therapeutics from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$0.75 B-37.82%
2023NZ$1.22 B-48.98%
2022NZ$2.39 B39.45%
2021NZ$1.71 B-34.37%
2020NZ$2.61 B107.09%
2019NZ$1.26 B13.75%
2018NZ$1.10 B-39.38%
2017NZ$1.83 B114.79%
2016NZ$0.85 B-39.65%
2015NZ$1.41 B174.68%
2014NZ$0.51 B

End of Day market cap according to different sources

On Nov 13th, 2024 the market cap of Revance Therapeutics was reported to be:

NZ$0.75 Billion
by Nasdaq info icon info icon
NZ$0.75 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$0.16 B-77.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$629.49 B 82,848.88%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$41.21 B 5,331.56%๐Ÿ‡บ๐Ÿ‡ธ USA